Filter News
Area of Research
- (-) National Security (6)
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (4)
- Biological Systems (2)
- Biology and Environment (66)
- Clean Energy (48)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (3)
- Fusion Energy (1)
- Isotopes (25)
- Materials (37)
- Materials for Computing (5)
- Neutron Science (17)
- Quantum information Science (1)
- Supercomputing (63)
News Topics
- (-) Bioenergy (4)
- (-) Biomedical (4)
- (-) Exascale Computing (1)
- (-) Frontier (1)
- (-) Isotopes (5)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (12)
- Artificial Intelligence (12)
- Big Data (6)
- Biology (5)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (21)
- Coronavirus (3)
- Cybersecurity (19)
- Decarbonization (3)
- Energy Storage (2)
- Environment (6)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (34)
- Neutron Science (9)
- Nuclear Energy (40)
- Partnerships (4)
- Physics (3)
- Quantum Science (1)
- Security (11)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.